All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group

Sanofi-Aventis to refinance its Eu16bn M&A loan, ultra-tight margin expected

Sanofi-Aventis, the French pharmaceuticals giant, is in talks with banks to refinance the Eu16bn loan that Sanofi-Synthélabo used to support its acquisition of a majority stake in Aventis last year, EuroWeek hears.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree